BMP — BMP Pharma Trading AG Income Statement
0.000.00%
Last trade - 00:00
- €21.53m
- €21.90m
- €0.00m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | GAS | GAS | GAS | GAS | GAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.007 | 0.001 | 0.001 | 0.004 | 0.002 |
Cost of Revenue | |||||
Gross Profit | 0.004 | 0 | 0 | 0.001 | -0.001 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.69 | 0.687 | 0.696 | 0.799 | 1.18 |
Operating Profit | -0.683 | -0.686 | -0.694 | -0.795 | -1.18 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.545 | 0.341 | 0.298 | 3.21 | 2.22 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.46 | 0.309 | 0.17 | 2.62 | 1.57 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.46 | 0.309 | 0.17 | 2.62 | 1.57 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.46 | 0.309 | 0.17 | 2.62 | 1.57 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.088 | 0.059 | 0.032 | 0.499 | 0.299 |
Dividends per Share |